RENE
Price:
$11.55
Market Cap:
$249.72M
Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.[Read more]
Industry
Shell Companies
IPO Date
2022-07-08
Stock Exchange
NASDAQ
Ticker
RENE
According to Cartesian Growth Corporation II’s latest financial reports and current stock price. The company's current ROE is 4.91%. This represents a change of 284.80% compared to the average of 1.28% of the last 4 quarters.
The mean historical ROE of Cartesian Growth Corporation II over the last ten years is -19.33%. The current 4.91% ROE has changed -125.39% with respect to the historical average. Over the past ten years (40 quarters), RENE's ROE was at its highest in in the September 2022 quarter at 5.41%. The ROE was at its lowest in in the December 2021 quarter at -17.52%.
Average
-19.33%
Median
4.75%
Minimum
-70.08%
Maximum
7.35%
Discovering the peaks and valleys of Cartesian Growth Corporation II ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.52%
Maximum Annual ROE = 7.35%
Minimum Annual Increase = -106.79%
Minimum Annual ROE = -70.08%
Year | ROE | Change |
---|---|---|
2023 | 7.35% | 54.52% |
2022 | 4.75% | -106.79% |
The current ROE of Cartesian Growth Corporation II (RENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-19.33%
5-year avg
-19.33%
10-year avg
-19.33%
Cartesian Growth Corporation II’s ROE is less than Pyrophyte Acquisition Corp. (3.27%), less than Rigel Resource Acquisition Corp. (0.13%), greater than Berenson Acquisition Corp. I (-30633.47%), less than Sculptor Acquisition Corp I (0%), less than TenX Keane Acquisition Ordinary Share (7.88%), less than Embrace Change Acquisition Corp. (3.33%), less than Home Plate Acquisition Corp. (3.47%), less than Bannix Acquisition Corp. (3.12%), greater than Noble Rock Acquisition Corporation (-0.92%), less than Global Blockchain Acquisition Corp. (5.37%), less than null (2.35%),
Company | ROE | Market cap |
---|---|---|
3.27% | $130.77M | |
0.13% | $168.24M | |
-30633.47% | $84.59M | |
0% | $302.45M | |
7.88% | $269.45M | |
3.33% | $52.43M | |
3.47% | $76.51M | |
3.12% | $45.27M | |
-0.92% | $87.43M | |
5.37% | $61.36M | |
2.35% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cartesian Growth Corporation II using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cartesian Growth Corporation II or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cartesian Growth Corporation II's ROE?
How is the ROE calculated for Cartesian Growth Corporation II (RENE)?
What is the highest ROE for Cartesian Growth Corporation II (RENE)?
What is the 3-year average ROE for Cartesian Growth Corporation II (RENE)?
What is the 5-year average ROE for Cartesian Growth Corporation II (RENE)?
How does the current ROE for Cartesian Growth Corporation II (RENE) compare to its historical average?